Nebenwirkungen · Hemgenix
Hemgenix 1 x 1013 genome copies/mL concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 12
HOS-142214 · Präparat HOS-098776
MedDRA System Organ ADR Frequency per Class (SOC) (Preferred term) patient Nervous system disorders Headache Very common Dizziness Common Gastrointestinal disorders Nausea Common General disorders and Influenza like illness Very common administration site conditions Fatigue, malaise Common Investigations Alanine aminotransferase increased, aspartate Very common aminotransferase increased, C-reactive protein increased Blood creatine phosphokinase increased, blood Common bilirubin increased Injury, poisoning and Infusion related reaction (Hypersensitivity, Very Common* procedural complications infusion site reaction, dizziness, eye pruritus, flushing, abdominal pain upper, urticaria, chest discomfort, pyrexia) * The frequency results from pooled infusion related reactions of similar medical concept. Individual infusion reactions occurred in 1 to 2 subjects with common frequency (incidence of 1.8 to 3.5%) within 24 hours post-dose.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-27T17:00:00Z · SHA-256 401706c55058fc08bee543581a5958c55aedec3e84eb254d503c8ac238757ce2 · Passage 9c01d9dd5bb9b15f6285f75545ab4c08d015143bd4af81f55659fd9614f6013d · Zeichen 1320–2901 im Abschnitt